Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.

A plant extract was found to effectively block an enzyme related to male hormone-related diseases.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Certain medications can cause serious side effects, including skin reactions, stroke, muscle disorders, tongue swelling, hair loss in women, and liver failure.

Low-dose oral minoxidil is effective and generally safe for treating hair loss in women.

Finasteride may help prevent prostate cancer.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

JAK inhibitors are generally safe for alopecia areata and atopic dermatitis, with mostly mild side effects.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Dutasteride successfully treated a woman's hair loss when other treatments failed.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Long-term use of androgens can help manage Hereditary Angioedema (HAE) but may cause serious side effects, so alternative treatments with fewer side effects are being considered.

Bicalutamide mesotherapy improved hair density in women with hair loss and was well received.

Both Diane 35 combinations effectively and safely reduce hirsutism and acne, with potential for better results if treatment extends beyond 12 months.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Androstenedione, a hormone supplement, doesn't improve muscle or performance and can cause harmful side effects.

Trienones are more effective at inhibiting the enzyme linked to hair loss than dienones.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

5% topical Minoxidil is the best treatment for female hair loss, improving hair density and thickness.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

Cyproterone acetate is a safe treatment that causes modest feminization in transgender female adolescents, and works better with added estrogens.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.